For patients who've plateaued on tirzepatide or semaglutide, quite possibly the most evidence-based mostly following move in 2026 is optimizing the current protocol. Altering dose timing, revisiting macronutrient distribution, or incorporating resistance education to maintain lean mass during continued weight loss.We may perhaps make use of your Ge